Who have Retroperitoneal haemorrhage with Meropenem - from FDA reports


Retroperitoneal haemorrhage is reported only by a few people who take Meropenem. We study 12,625 people who have side effects while taking Meropenem from FDA. Among them, 5 have Retroperitoneal haemorrhage. Find out below who they are, when they have Retroperitoneal haemorrhage and more.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.


Peer to Peer mobile support

Peer support for this study is available on our Ginger Health app. It's free, anonymous and secure. The app is ideal for people taking multiple medications or having multiple conditions.



On Feb, 23, 2019

12,625 people reported to have side effects when taking Meropenem.
Among them, 5 people (0.04%) have Retroperitoneal haemorrhage


Number of reports submitted per year:

Could Meropenem cause Retroperitoneal haemorrhage?

Gender of people who have Retroperitoneal haemorrhage when taking Meropenem *:

  • female: 80 %
  • male: 20 %

Age of people who have Retroperitoneal haemorrhage when taking Meropenem *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Top conditions involved for these people *:

  1. Preventive Health Care: 2 people, 40.00%
  2. Sepsis (a severe blood infection that can lead to organ failure and death): 1 person, 20.00%
  3. Pulmonary Embolism (blockage of the main artery of the lung): 1 person, 20.00%
  4. Pneumonia: 1 person, 20.00%
  5. Paroxysmal Supraventricular Tachycardia: 1 person, 20.00%
  6. Non-Hodgkin's Lymphoma Unspecified Histology Indolent (malignant (cancer) cells form in the lymph system- unspecified histology indolent): 1 person, 20.00%
  7. Disseminated Intravascular Coagulation (systemic activation of blood coagulation): 1 person, 20.00%
  8. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 1 person, 20.00%
  9. Cerebral Infarction (less blood supply to brain resulting tissue damage): 1 person, 20.00%
  10. Bone Marrow Conditioning Regimen: 1 person, 20.00%

Top co-used drugs for these people *:

  1. Aspirin: 2 people, 40.00%
  2. Levemir: 1 person, 20.00%
  3. Bactrim: 1 person, 20.00%
  4. Colace: 1 person, 20.00%
  5. Crestor: 1 person, 20.00%
  6. Cubicin: 1 person, 20.00%
  7. Dilantin: 1 person, 20.00%
  8. Enoxaparin Sodium: 1 person, 20.00%
  9. Fragmin: 1 person, 20.00%
  10. Furosemide: 1 person, 20.00%

Top other side effects for these people *:

  1. Fever: 2 people, 40.00%
  2. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 40.00%
  3. Haemoglobin Decreased: 2 people, 40.00%
  4. Ejection Fraction Decreased (systolic heart failure): 1 person, 20.00%
  5. Arrhythmias (irregular heartbeat): 1 person, 20.00%
  6. Blood Creatine Phosphokinase Increased: 1 person, 20.00%
  7. Cardio-Respiratory Arrest (sudden dysfunction of heart and lungs): 1 person, 20.00%
  8. Catheter Related Complication: 1 person, 20.00%
  9. Cytokine Release Syndrome (immediate complication occurring with the use of anti-t cell antibody infusions): 1 person, 20.00%
  10. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 1 person, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you have Retroperitoneal haemorrhage while taking Meropenem?


You are not alone:




Related studies

Meropenem

Meropenem has active ingredients of meropenem. (latest outcomes from Meropenem 12,663 users)

Retroperitoneal haemorrhage

Retroperitoneal haemorrhage (bleeding between the peritoneum and the posterior abdominal wall) has been reported by people with atrial fibrillation/flutter, stroke, deep venous thrombosis, pulmonary embolism, high blood pressure (latest reports from 3,102 Retroperitoneal haemorrhage patients).


Drugs that are associated with Retroperitoneal haemorrhage
Retroperitoneal haemorrhage (578 drugs)
Could your condition cause Retroperitoneal haemorrhage
Retroperitoneal haemorrhage (310 conditions)
Meropenem side effects

Browse by gender and age

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+


Browse all side effects of Meropenem
a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


What would happen?

Predict new side effects and undetected conditions when you take Meropenem and have Retroperitoneal haemorrhage


FDA reports used in this study



Recent updates

Recent general studies
Recent personal studies

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Submit your testimonial

  • Please fill in your Testimonial.
  • Please enter a minimum of 10 characters for your Testimonial.
  • Please fill in your Name.

Please wait...

{progressItem}

Thank you!